These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32048273)

  • 1. A key step towards setting a benchmark for tackling transplant-associated thrombotic microangiopathy.
    Scordo M; Giralt SA
    Br J Haematol; 2020 Jun; 189(6):1006-1009. PubMed ID: 32048273
    [No Abstract]   [Full Text] [Related]  

  • 2. De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.
    Patel A; Knorr JP; Campos S; Khanmoradi K; Zaki RF; Bradauskaite G
    Exp Clin Transplant; 2016 Apr; 14(2):230-4. PubMed ID: 26030297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic Microangiopathy in a Transplant Recipient.
    Mundra VRR; Mannon RB
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1251-1253. PubMed ID: 30042222
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombotic microangiopathy after kidney transplantation: lessons from a transplant tourist.
    Shendi AM; Aly AA; Alsaad KO; Shah Y; Ali TZ; Broering DC; Aleid HA
    J Nephrol; 2023 May; 36(4):1191-1195. PubMed ID: 36795314
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in the diagnosis and management of transplant-associated thrombotic microangiopathy].
    Yang LP; Liu X; Zhang XH
    Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):693-699. PubMed ID: 34547882
    [No Abstract]   [Full Text] [Related]  

  • 6. Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet.
    Renella R; Stickney C; Keswani M; Mancuso T; Casavant D; Ferguson M; Narla A
    Am J Hematol; 2012 Aug; 87(8):816-8. PubMed ID: 22407784
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of transplant-associated thrombotic microangiopathy].
    Ikezoe T
    Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chinese consensus on the diagnosis and management of transplant-associated thrombotic microangiopathy (2021)].
    Hematopoietic Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association
    Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):177-184. PubMed ID: 33910301
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombotic microangiopathy following haematopoietic stem cell transplant.
    Seaby EG; Gilbert RD
    Pediatr Nephrol; 2018 Sep; 33(9):1489-1500. PubMed ID: 28993886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
    Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
    Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive multifocal cerebral infarction in a young kidney transplant recipient due to thrombotic microangiopathy.
    Haghikia A; Heeren M; Bockmeyer C; Haubitz B; Gwinner W
    BMC Nephrol; 2014 Apr; 15():59. PubMed ID: 24708483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant-associated thrombotic microangiopathy: Diagnostic challenges and management strategies.
    Elemary M; Sabry W; Seghatchian J; Goubran H
    Transfus Apher Sci; 2019 Jun; 58(3):347-350. PubMed ID: 31097308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic Microangiopathy and Acute Kidney Injury: Navigating the Differential Diagnosis.
    Gupta S; Jayaraman R; Rabold E; Goyal P; Mattana J
    Am J Ther; 2019; 26(5):e633-e635. PubMed ID: 30277907
    [No Abstract]   [Full Text] [Related]  

  • 14. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?
    Vaughn JL; Zhao Q; Epperla N; Puto M; Roddy J; Elder P; Blum W; Klisovic R; Jaglowski S; Penza S; William B; Andritsos L; Brammer JE; Hofmeister C; Efebera Y; Benson D; Devine S; Cataland S; Vasu S
    Bone Marrow Transplant; 2019 Jun; 54(6):913-916. PubMed ID: 30413812
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle.
    Wehrmann F; von Bergwelt-Baildon A; Schönermarck U
    J Nephrol; 2023 Nov; 36(8):2175-2177. PubMed ID: 37256539
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombotic microangiopathy associated with tuberculous infection.
    Masumoto S; Tada M; Katsuma A; Minami E; Katagiri D; Shibata M; Hinoshita F
    Intern Med; 2011; 50(17):1825-8. PubMed ID: 21881282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human immunodeficiency virus-associated thrombotic microangiopathies].
    Gilardin L; Malak S; Schoindre Y; Galicier L; Veyradier A; Coppo P
    Rev Med Interne; 2012 May; 33(5):259-64. PubMed ID: 22280852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndromes of thrombotic microangiopathy.
    George JN; Nester CM
    N Engl J Med; 2014 Aug; 371(7):654-66. PubMed ID: 25119611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matsui H, Arai Y, Imoto H, et al. Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT. Blood Adv. 2020;4(13):3169-3179.
    Blood Adv; 2024 Apr; 8(7):1698. PubMed ID: 38551596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.